Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 5

Sponsor Class

OTHER 10INDUSTRY 5FED 1

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Neoplasms 1905Breast Neoplasms 1425Carcinoma, Non-Small-Cell Lung 1178Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 623Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Lymphoma 374Recurrence 373Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

pimodivir 1Rosuvastatin Calcium 1Cyclosporine 1Adalimumab 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Healthy × Clear all
NCT03628638 2021-02-15

2016-11

Exact Sciences Corporation

Completed
1,718 enrolled

Healthy

NCT03768609 2019-04-29

A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults

Janssen-Cilag International NV

Phase 1 Completed
18 enrolled

Healthy

NCT02912247 2019-03-07

Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Completed
183 enrolled

Healthy

NCT03242239 2017-08-21

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and HerceptinĀ® in Healthy Subjects

Alteogen, Inc.

Phase 1 Completed
105 enrolled

Healthy

NCT02300363 2015-07-09

DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin

Lexicon Pharmaceuticals

Phase 1 Completed
24 enrolled

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚔